Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning

Ye Zhang1, Er-wei Gu, Jian Zhang

  • 1Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. zhangye@mail.hf.ah.cn

Abstract

Insights

Morphine-induced preconditioning (MPC) and ischemic preconditioning (IPC) protect rat hearts from injury. p38 mitogen-activated protein kinases (MAPK) mediate MPC, but trigger and mediate IPC.

Area of Science:

  • Cardiovascular Science
  • Molecular Cardiology
  • Pharmacology

Background:

  • p38 mitogen-activated protein kinases (MAPK) are crucial for cardioprotection during ischemic preconditioning (IPC).
  • The role of p38 MAPK in morphine-induced preconditioning (MPC) remains unclear.

Purpose of the Study:

  • To investigate whether p38 MAPK activation mediates the protective effects of MPC against myocardial ischemia-reperfusion injury in a rat model.
  • To compare the role of p38 MAPK in MPC versus IPC.

Main Methods:

  • Male Spargue-Dawley rats were subjected to control, p38 MAPK inhibition (SB 203580), MPC, IPC, or combinations thereof.
  • Infarct size (IS) as a percentage of area at risk (AAR) was determined using triphenyltetrazolium staining.
  • p38 MAPK protein expression was assessed via Western blotting.

Main Results:

  • Both IPC and MPC significantly reduced infarct size compared to control.
  • Inhibition of p38 MAPK abolished the protective effect of IPC but not MPC when administered before preconditioning.
  • Inhibition of p38 MAPK prior to sustained ischemia diminished the protective effects of both MPC and IPC.
  • Phospho-p38 MAPK levels increased rapidly during ischemia and reperfusion in IPC, but only during reperfusion in MPC.

Conclusions:

  • p38 MAPK acts as a mediator in MPC.
  • p38 MAPK functions as both a trigger and a mediator in IPC.
  • These findings differentiate the mechanistic roles of p38 MAPK in two distinct preconditioning paradigms.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...